Histopathology of Pulmonary Hypertension
Authors:
- Sang-Do LeeSLSang-Do Lee
- Carlyne C. CoolCCCarlyne C. Cool
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.Journal of Clinical Investigation, 1998
- 5-Lipoxygenase and 5-Lipoxygenase Activating Protein (FLAP) Immunoreactivity in Lungs from Patients with Primary Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Prostaglandins Induce Vascular Endothelial Growth Factor in a Human Monocytic Cell Line and Rat Lungs via cAMPAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Monoclonal Origin of Multicentric Kaposi's Sarcoma LesionsNew England Journal of Medicine, 1997
- Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infectionHuman Pathology, 1997
- cGMP-Elevating Agents Suppress Proliferation of Vascular Smooth Muscle Cells by Inhibiting the Activation of Epidermal Growth Factor Signaling PathwayCirculation, 1997
- Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1995
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionNew England Journal of Medicine, 1992
- Use of Restriction Fragment Length Polymorphisms to Determine the Clonal Origin of Human TumorsScience, 1985